| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
BACTERIAL PATHOGENICITY |
Department of Microbiology, University of Otago, PO Box 56, Dunedin, New Zealand
Corresponding author: Professor J. R. Tagg (e-mail: john.tagg{at}stonebow.otago.ac.nz).
Received 22 Nov. 1999; revised version accepted 31 Jan 2000.
Abstract
Variants of large colony ß-haemolytic Lancefield group A, C and G streptococci that are non-haemolytic or 
-haemolytic on sheep blood agar have been detected in clinical specimens due to their enhanced haemolytic activity when grown on a new selective and differential blood agar medium containing colistin, nalidixic acid and pH 7.5-adjusted PIPES buffer (CNA-P). The large colony Lancefield group C and G isolates were identified as Streptococcus dysgalactiae subsp. equisimilis by API 20 Strep classification and 16S rDNA profiling. The haemolytic activity of these variants on various blood agar media, including CNA-P, was closely similar to that of known streptolysin S-defective mutants of S. pyogenes and was blocked by addition of cholesterol, a specific inhibitor of the streptolysin O family of haemolysins. As haemolysin variants could be detected in large numbers in cultures from patients with clinical symptoms of pharyngitis it is suggested that they may function as primary pathogens in such infections. The high frequency with which haemolysin variants were isolated from clinical specimens during a 3-month trial (3%, 13% and 10%, respectively, of group A, C and G streptococcal isolates) indicated that a substantial proportion of streptococcal infections may go undetected if only conventional sheep blood agar media are used in clinical laboratories for the detection of ß-haemolytic streptococci. As haemolysin variants have been implicated in the development of serious streptococcal sequelae, further investigation of the full extent of their contribution to streptococcal disease is indicated.
This article has been cited by other articles:
|
|
 |
|
  V. Savini, C. Catavitello, M. Talia, A. Manna, F. Pompetti, G. Di Bonaventura, N. Di Giuseppe, F. Febbo, A. Balbinot, S. Di Zacomo, et al. {beta}-Lactam Failure in Treatment of Two Group G Streptococcus dysgalactiae subsp. equisimilis Pharyngitis Patients J. Clin. Microbiol., February 1, 2008; 46(2): 814 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P J Turner and S. L Gunn Fatal case of sepsis caused by a non-haemolytic strain of Streptococcus pyogenes J. Clin. Pathol., September 1, 2007; 60(9): 1057 - 1057. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Horii, S. Izumida, K. Takeuchi, T. Tada, J. Ishikawa, and K. Tsuboi Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G {alpha}-haemolytic Streptococcus dysgalactiae subsp. equisimilis. J. Med. Microbiol., July 1, 2006; 55(Pt 7): 953 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Y. Woo, J. L. L. Teng, S. K. P. Lau, P. N. L. Lum, K.-W. Leung, K.-L. Wong, K.-W. Li, K.-C. Lam, and K.-Y. Yuen Analysis of a Viridans Group Strain Reveals a Case of Bacteremia Due to Lancefield Group G Alpha-Hemolytic Streptococcus dysgalactiae subsp. equisimilis in a Patient with Pyomyositis and Reactive Arthritis J. Clin. Microbiol., February 1, 2003; 41(2): 613 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Cimolai, C. Trombley, and N. M. E Bhanju Nonhemolytic Streptococcus pyogenes Causing Invasive Infection Clinical Pediatrics, July 1, 2002; 41(6): 453 - 453. [PDF]
|
|
|
|
|
|
M. B. Taylor and T. Barkham Fatal Case of Pneumonia Caused by a Nonhemolytic Strain of Streptococcus pyogenes J. Clin. Microbiol., June 1, 2002; 40(6): 2311 - 2312. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |
